Resmed’s decision to sell MatrixCare to PE firm Frazier Healthcare Partners comes less than a decade after its $750m acquisition of the software business.

Selling the software business to Frazier Healthcare Partners will allow the respiratory device maker to shift more resources to faster-growing parts of its portfolio.

July 7 (Reuters) - ResMed said on Tuesday it would sell its software business MatrixCare to private equity firm Frazier Healthcare Partners for $490 million in cash, as the health technology company ...

Resmed (RMD) said on Tuesday it agreed to sell its MatrixCare business to private equity firm Frazier Healthcare Partners as the medical device maker sharpens its focus on sleep, breathing and ...

MEMPHIS, Tenn.--(BUSINESS WIRE)--Hospice Dynamix™, a predictive analytics software platform from Diversified Health Technology (DHT), today announced a strategic partnership with MatrixCare, a leading ...

BLOOMINGTON, MN--(Marketwired - Mar 6, 2014) - MDI Achieve, provider of the MatrixCare Electronic Health Record for long-term care, has entered into a definitive agreement to purchase the assets of ...